TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth Tilt how tags are computed

Q1 2025 · 202 positions · Total reported value $1.81B · Top-10 concentration 39.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 202 equity positions with a combined reported value of $1.81B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 39.2% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt.

The largest disclosed positions as of Q1 2025 were TARS ($126.10M), LKFT ($99.52M), AUPH ($80.64M). By sector, the heaviest allocations are Health Care 73.0%, Technology 2.2%. Versus the prior quarter, allocation shifted toward Other (+5.4pp) and away from Technology (-0.6pp), Health Care (-5.0pp).

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 84% of names.

The largest new positions opened in Q1 2025 were SYRE ($33.08M), SLRN ($24.25M), KROS ($11.21M).

Of the 1 positions fully exited versus the prior quarter, the largest were OMIC ($7.23M), ALMS ($4.72M), MRNS ($878.61K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • SYRE SPYRE THERAPEUTICS INC · $33.08M
  • SLRN ACELYRIN INC · $24.25M
  • KROS KEROS THERAPEUTICS INC · $11.21M
  • ARVN ARVINAS INC · $9.78M
  • BABA ALIBABA GROUP HLDG LTD · $9.26M
  • PLRX PLIANT THERAPEUTICS INC · $8.10M
  • VERA VERA THERAPEUTICS INC · $3.60M
  • VIR VIR BIOTECHNOLOGY INC · $3.24M

Fully Exited (vs previous quarter)

  • OMIC SINGULAR GENOMICS SYSTEMS IN · prev qtr: $7.23M
  • ALMS ALUMIS INC · prev qtr: $4.72M
  • MRNS MARINUS PHARMACEUTICALS INC · prev qtr: $878.61K
  • EDIT EDITAS MEDICINE INC · prev qtr: $508.00K
  • ALVR ALLOVIR INC · prev qtr: $231.95K
  • RLMD RELMADA THERAPEUTICS INC · prev qtr: $104.43K
  • IMRX IMMUNEERING CORP · prev qtr: $26.56K

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 73.0%
Technology 2.2%
Financials 0.2%
Other 22.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.45M $126.10M 6.98%
6.98%
Add
2 3.96M $99.52M 5.51%
5.51%
Add
3 10.03M $80.64M 4.46%
4.46%
Add
4 5.75M $74.58M 4.13%
4.13%
Add
5 5.00M $60.12M 3.33%
3.33%
Hold
6 4.94M $57.03M 3.15%
3.15%
Add
7 1.92M $56.84M 3.14%
3.14%
Add
8 1.24M $55.73M 3.08%
3.08%
Hold
9 1.00M $50.96M 2.82%
2.82%
Add
10 2.12M $47.05M 2.60%
2.60%
Add
11 2.79M $37.65M 2.08%
2.08%
Add
12 2.05M $33.08M 1.83%
1.83%
New
13 220.00K $29.02M 1.61%
1.61%
Reduce
14 1.55M $28.72M 1.59%
1.59%
Add
15 2.90M $28.27M 1.56%
1.56%
Add
16 830.00K $28.16M 1.56%
1.56%
Add
17 1.50M $24.91M 1.38%
1.38%
Hold
18 270.00K $24.59M 1.36%
1.36%
Hold
19 9.82M $24.25M 1.34%
1.34%
New
20 190.00K $23.59M 1.30%
1.30%
Add
21 317.50K $21.26M 1.18%
1.18%
Hold
22 8.07M $21.14M 1.17%
1.17%
Hold
23 11.05M $21.00M 1.16%
1.16%
Add
24 1.05M $20.83M 1.15%
1.15%
Add
25 766.94K $19.72M 1.09%
1.09%
Hold
26 250.00K $18.38M 1.02%
1.02%
Add
27 1.20M $17.70M 0.98%
0.98%
Add
28 150.00K $16.59M 0.92%
0.92%
Hold
29 2.10M $16.42M 0.91%
0.91%
Add
30 2.69M $16.05M 0.89%
0.89%
Add
31 27.57K $15.89M 0.88%
0.88%
Add
32 400.00K $15.50M 0.86%
0.86%
Hold
33 142.57K $15.45M 0.85%
0.85%
Hold
34 270.00K $14.97M 0.83%
0.83%
Hold
35 4.80M $14.35M 0.79%
0.79%
Hold
36 2.75M $13.75M 0.76%
0.76%
Hold
37 1.10M $13.10M 0.72%
0.72%
Hold
38 7.06M $12.98M 0.72%
0.72%
Add
39 3.06M $12.45M 0.69%
0.69%
Add
40 1.83M $11.60M 0.64%
0.64%
Add
41 300.00K $11.33M 0.63%
0.63%
Hold
42 1.10M $11.21M 0.62%
0.62%
New
43 1.40M $11.14M 0.62%
0.62%
Hold
44 1.85M $10.94M 0.60%
0.60%
Add
45 2.35M $10.80M 0.60%
0.60%
Hold
46 37.00K $10.07M 0.56%
0.56%
Hold
47 1.39M $9.78M 0.54%
0.54%
New
48 281.20K $9.33M 0.52%
0.52%
Hold
49 70.00K $9.26M 0.51%
0.51%
New
50 266.50K $9.07M 0.50%
0.50%
Hold

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2025-Q1?

In its 2025-Q1 13F filing, TANG CAPITAL MANAGEMENT LLC reported 202 equity positions worth $1.81B in aggregate; its largest disclosed positions were TARS ($126.10M), LKFT ($99.52M), AUPH ($80.64M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $1.81B of long equity holdings across 202 positions as of 2025-Q1. Top-10 holdings account for 39.2% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →